| |
Peripheral Arterial Occlusive Disease |
| No |
Peripheral arterial occlusive disease-Update guidelines & Innovations |
| 1 |
Updated guideline and landmark study in PAD |
| 2 |
BASIL-2 trial versus BEST-CLI trial |
| 3 |
What is the best solution for complex AIOD disease? |
| 4 |
Role of IVUS and Shockwave in aortoiliac reconstruction: Challenging the gold standard of ABFB |
| 5 |
Drug coated balloons for BTK disease: What's new for Paclitaxel and Sirolimus |
| 6 |
5 Inventions and Techniques that changing my endovascular practice |
| 7 |
New innovation for overcome calcification in BTK vessels |
| 8 |
Update in endovascular treatment strategy in femoropopliteal lesion |
| 9 |
Treatment for No-Option CLTI after revascularization |
| 10 |
Update in endovascular management strategy for ALI |
| No |
Peripheral arterial occlusive disease-1 |
| 1 |
Diabetic foot ulcer: Back to the Future |
| 2 |
Catheter-based revascularisation in acute limb ischemia: How I do it? |
| 3 |
Hybrid revascularization in ALI: Encountering with thrombus, emboli and culprit lesion |
| 4 |
How to deal with ischemic-reperfusion injury in modern era |
| 5 |
Arterial thoracic outlet syndrome: Recognition and Intervention |
| 6 |
Pythium insidiosum and vascular complications |
| 7 |
CO2 angiography: How to get better images |
| 8 |
Transradial peripheral arterial intervention |
| 9 |
Re-entry deivces in CTO lesion |
| 10 |
FIRST TIME DATA RELEASE: TINTIN trial investigating the combination of DCB and bare metal stents: 5-year result |
| No |
Peripheral arterial occlusive disease-2 |
| 1 |
Implementation of CLTI protocol for improving limb salvage |
| 2 |
Pre-operative perfusion measurement tools in CLTI |
| 3 |
Updating the result of covered stent v/s open revascularization in complex AIOD |
| 4 |
Guide wire crossing in CTO lesion in AIOD |
| 5 |
Tip & trick for complex aortoiliac reconstruction ChCERAB & CERAB |
| 6 |
Endovascular treatment options in CFA disease |
| 7 |
Technical aspect of endovascular treatment of multi-level occlusive disease |
| 8 |
Technical aspect of open vascular bypass in multi-level occlusive disease |
| 9 |
Technical aspect of hybrid operation in multi-level occlusive disease |
| 10 |
Strategy for CLTI in non-reconstructable distal arteries |
| No |
Peripheral arterial occlusive disease-3 |
| 1 |
Update in outcome of DCB v/s Stent in complex femoropopliteal occlusive disease |
| 2 |
Update in the debulking atherectomy in femoropopliteal occlusive disease |
| 3 |
Updated management in in-stent restenosis |
| 4 |
Challenging technique in the CTO and calcification in BTK lesion |
| 5 |
Future trend of Drug Eluting Technologies in BTK lesion |
| 6 |
IVUS and OCT: Better vision for better outcome |
| 7 |
Surgical tactics in crural and below the ankle bypass procedure |
| 8 |
Inframalleolar intervention in CLTI: When and How? |
| 9 |
Surgical technique in open deep vein arterialization |
| 10 |
Experience with Limflow procedure: Promise I, II, III and Clarity Studies |
| No |
Peripheral arterial occlusive disease-asia |
| 1 |
Current status of CLTI treatment in Japan Reviewing SPINACH study |
| 2 |
Long-term outcomes of aortoiliac artery stenting |
| 3 |
SUPERA stent: The mimetic stent in non-SFA territories |
| 4 |
The efficacy of atherectomy device in de novo or restenotic femoropopliteal lesions |
| 5 |
Long-term outcomes of percutaneous atherectomy and DEB |
| 6 |
Post-PTA dissection: Classification, Prevention & Treatment |
| 7 |
What is the most advanced treatment for patients with no-option CLTI? |
| 8 |
Distal bypass as a tool for limb salvage |
| 9 |
Long-term fate of popliteal artery entrapment syndrome |
| 10 |
Long-term result of open v/s endovascular treatment of Takayasu arteritis |
| No |
Peripheral arterial occlusive disease-How I do it? |
| 1 |
Limb salvage with endovascular DVA: Steps & Tricks for success |
| 2 |
All my tips and tricks for retrograde and bidirectional crossing for difficult lesions |
| 3 |
Vessel preparation in femoropopliteal lesion: Tips & Tricks |
| 4 |
CERAB in complex AIOD: How I do it? |
| 5 |
Percutaneous femoropopliteal bypass |
| |
Aneurysm |
| No |
Aneurysm-Update guidelines & Innovations |
| 1 |
Vascular deformation mapping in aortic connective tissue disease to predict intimal tear during follow-up |
| 2 |
Open v/s Complex endovascular repair of aortic aneurysms Guideline in 2024 |
| 3 |
Guidelines and multidisciplinary approach in open repair for pararenal and suprarenal AAA |
| 4 |
Guideline of management for aortic arch Open v/s Endovascular v/s Hybrid, which will be the first option? |
| 5 |
Computer modeling for patient-directed type B aortic dissection care |
| 6 |
Updated guideline in management of aorto-iliac aneurysms (ESVS 2024) |
| 7 |
Guideline in management acute and chronic type B aortic dissection |
| 8 |
Current guideline in management infected abdominal aortic aneurysm |
| 9 |
Novel bidirectional double cuffed inner branches for complex endovascular aortic repair |
| 10 |
Updated guideilne of preoperative cardiac evaluation in vascular surgery |
| No |
Aneurysm-1 |
| 1 |
Complex AAA Endovascular / Open / Hybrid repair |
| 2 |
Is coeliac artery fenestration stenting a requirement in Fenestrated EVAR? |
| 3 |
The link between elevated cancer risk and endovascular aortic repair |
| 4 |
Physician-modified endovascular grafts for juxta and pararenal AAA Technical challenges and learning outcomes |
| 5 |
Impact of aortic neck length and angulation for outcomes in AAA with severe neck angulation |
| 6 |
Update in Harborview Risk Score for ruptured AAA Is it still accurate? |
| 7 |
Current management of internal ilac artery aneurysms |
| 8 |
Treating diversed abdominal aortic anatomies Current technology assessment |
| 9 |
Decade of EVAR durability with new data on sac regression |
| 10 |
The situation of mycotic AAA therapy in China. |
| No |
Aneurysm-2 |
| 1 |
The current landscape of endosuture aneurysm repair (ESAR) |
| 2 |
Five-year outcomes for bell bottom, iliac branch endoprosthesis, coil and cover approaches GREAT registry |
| 3 |
Aortoiliac aneurysm treatment Lesson learned from Ramathibodi hospital |
| 4 |
Complex EVAR procedures in challenging anatomy |
| 5 |
Lessons learned in managing infected AAA |
| 6 |
FESAR (single Fenestrated Endosuture Aneurysm Repair) for very short neck AAA |
| 7 |
Delayed diasters of abdominal aortic endografts |
| 8 |
The suitability of conventional EVAR for ruptured AAA in Asia |
| 9 |
Physician modified endograft for juxta and pararenal AAA |
| 10 |
Type 2 endoleak treatment options and outcomes |
| No |
Aneurysm-3 |
| 1 |
Contemporary options for management of the left subclavian artery and expected outcome |
| 2 |
Aortic arch devices Fenestrated v/s Branched grafts |
| 3 |
Long-term outcomes of open aortic arch repair Strategies to improve perioperative outcomes and make it durable. |
| 4 |
Endovascular aortic arch repair with inner branch stent graft Lesson learned from King Chulalongkorn Memorial Hospital |
| 5 |
Value of ascending aortic banding as primary or adjunctive treatment for aortic arch lesions |
| 6 |
Advances and new strategies in open surgical repair of aortic arch pathologies |
| 7 |
Insights in using different aortic arch branched endografts Differences, Advantages and Challenges. |
| 8 |
Unibody single-branched aortic arch device Indications & Clinical experiences |
| 9 |
Neurological complications after aortic arch repairs How to minimize them? |
| 10 |
Aortic arch surgery in acute type A aortic dissection Strategic treatment and Outcomes |
| No |
Aneurysm-4 |
| 1 |
Intravascular ultrasound-guided transcaval approach for thoracic endovascular aneurysm repair |
| 2 |
Remaining indications for cerebrospinal fluid drainage during endovascular thoracoabdominal aneurysm repair |
| 3 |
Advancements in surgical techniques for open thoracoabdominal aortic aneurysm repair Experience 600 cases |
| 4 |
Concerning points of branched grafts in complex aortic aneurysm |
| 5 |
Real world experience with a low profile thoracic endograft |
| 6 |
Simplify complexity of TAAA patients with branch devices |
| 7 |
Best medical therapy for uncomplicated acute type B aortic dissection |
| 8 |
Management of aortic lesions in Takayasu arthritis |
| 9 |
Why I choose Branches v/s Fenestrations? |
| 10 |
Update in management of aortic intramural hematoma |
| No |
Aneurysm-Asia |
| 1 |
Hemodynamic evaluation of AAA using in vivo hemodynamic model and computational model |
| 2 |
Endovascular treatment of short aortic neck AAA using Endoanchor |
| 3 |
Endovascular treatment of type Ia endoleak |
| 4 |
Long-term outcome of large diameter stent graft use during EVAR |
| 5 |
Open surgical conversion of EVAR failure |
| 6 |
Prediction of in-hospital mortality after ruptured AAA repair using auto-segmentation of retroperitoneal hematoma |
| 7 |
Treatment strategy of infected aortic graft or stent graft |
| 8 |
Value of ascending aortic banding as primary or adjunctive treatment for aortic arch lesions |
| 9 |
The impact of arch bird-beak configuration on aortic remodeling after TEVAR |
| 10 |
Distal stent-graft induced new entry tears (SINEs) on aortic remodeling of chronic TBADs How to prevent & treat |
| 11 |
How to deal with complex abdominal aortic disease? |
| 12 |
Thoracic endovascular aortic repair (TEVAR) The journey begins for the vascular surgeons of Bangladesh |
| No |
Aneurysm-How I do it? |
| 1 |
Endovascular approach for aortic arch pathology |
| 2 |
Strategies for complex aortic repair for chronic aortic dissection and what are the unmet needs |
| 3 |
Effective strategies and techniques for fenestrated grafts in complex aortic aneurysms |
| 4 |
Tips and tricks for open retroperitoneal exposure of the aorta and its branches |
| 5 |
Step-by-step procedures for open complex aortic aneurysm repair |
| 6 |
Endovascular aneurysm repair in AAA with short neck How I do it? |
| 7 |
How to optimize the planning of Fenestrated/ Branched grafts for TAAA ? |
| |
Carotid Disease |
| No |
Carotid disease |
| 1 |
Duplex ultrasonography for carotid disease |
| 2 |
Severe symptomatic carotid artery stenosis CEA v/s CAS |
| 3 |
Asymptomatic carotid stenosis Current management |
| 4 |
Optimizing carotid endarterectomy outcomes Anesthesia & Closure |
| 5 |
Carotid endarterectomy 10-year follow up in a university hospital |
| 6 |
Decision making in patients with carotid artery stenosis and ischemic heart disease |
| 7 |
Postoperative cardiac complications in vascular surgery |
| 8 |
Postoperative complications after carotid endartectomy and management |
| 9 |
Transcarotid artery revascularization (TCAR) Surgical technique & Outcomes |
| 10 |
Current management of carotid artery aneurysm |
| |
Venous Disease |
| No |
Venous disease-Update guidelines & Innovations |
| 1 |
Updated guideline in duplex scanning in CVD |
| 2 |
Updated guideline in medical treatment and compression therapy of CVD |
| 3 |
Updated guideline in truncal ablation and perforator ablation |
| 4 |
Updated guidleine in ICVO and deep vein reflux |
| 5 |
Updated guideline in pelvic venous disorder |
| 6 |
Updated guideline in VTE prophylaxis in surgical patient |
| 7 |
Updated guideline in DVT (Medical treatment) |
| 8 |
Updated guideline in PE |
| 9 |
Updated guideline in acute intervention in DVT |
| 10 |
Updated guideline in management of venous leg ulcer |
| No |
Venous disease-1 |
| 1 |
Thermal ablation Is it still the gold standard? |
| 2 |
Cyanoacrylate closure Is it the best treatment for truncal vein ablation? |
| 3 |
Complications of cyanoacrylate closure |
| 4 |
TT v/s NTNT Is it time to stop the argument ? |
| 5 |
VTE prophylaxis for endovenous truncal ablation |
| 6 |
SSV ablation What is the best choice? |
| 7 |
Concomittent phlebectomy after intervention of saphenous ablation for primary varicose vein |
| 8 |
Laser crossectomy & Below knee truncal laser ablation Techniques & Results |
| 9 |
When & How to treat pathologic perforating vein |
| 10 |
Recurrent varicose vein The way to go? |
| No |
Venous disease-2 |
| 1 |
Updated management of phlegmasia cerulea dolen |
| 2 |
Acute DVT intervention Who will get the benefit? |
| 3 |
Stent v/s Not Stent after thrombus removal of ilio-femoral DVT |
| 4 |
Open venous thrombectomy Does it still have a role in 2024? |
| 5 |
CDT v/s mechanical thrombectomy for acute ilio-femoral DVT What is the current evidence? |
| 6 |
How to deal with difficult IVC filter removal? |
| 7 |
Role of stenting in thoracic outlet syndrome with DVT |
| 8 |
Acute intervention for PE |
| 9 |
Current role of DOAC in VTE of CKD patients |
| 10 |
Updated guideline in perioperative management for VTE |
| No |
Venous disease-3 |
| 1 |
Classification of chronic iliofemoral venous obstruction and its clinical impact |
| 2 |
Tips & tricks in iliofemoral / caval recanalization and stenting |
| 3 |
Complications of iliofemoral venous stenting |
| 4 |
How to deal with iliac stent thrombosis |
| 5 |
Chronic deep venous obstruction Venous stenting v/s Conservative treatment |
| 6 |
Update in venous valve replacement for deep vein reflux |
| 7 |
The management of combined ilio-femoral and femoro-popliteal vein thrombosis |
| 8 |
Combined truncal vein reflux and ICVO for venous leg ulcer |
| 9 |
Current and future physiologic assessment in deep venous intervention |
| 10 |
Current management of antithrombotic after iliac venous stenting |
| No |
Venous disease-4 |
| 1 |
Sclerotherapy Basic to get good results |
| 2 |
Guideline of management of superficial vein thrombosis |
| 3 |
Management of mixed arterial and venous leg ulcer |
| 4 |
Management of recalcitrant VLU |
| 5 |
Advanced wound dressing for VLU |
| 6 |
Leg exercise for venous ulcer healing |
| 7 |
SVP based zonal symptom assessment in pelvic venous disorders |
| 8 |
Duplex ultrasound for pelvic venous disorders |
| 9 |
Bottom up or top down approach for treatment of pelvic venous disorders |
| 10 |
Pelvic vein embolization Tips and Trick |
| No |
Venous disease-Asia |
| 1 |
Changes of the stump length after endovenous therapy of incompetent sahenous vein |
| 2 |
VTE How and when to intervene |
| 3 |
Post-thrombotic syndrome Pathophysiology and Treatment strategies |
| 4 |
Effectiveness of IVUS for iliac vein stenting |
| 5 |
Indian series with OBLIQUS ( Dedicated Venous Stent ) for May-Thurners. |
| No |
Venous disease-How I do it? |
| 1 |
Technique in endovenous thermal ablation RFA & Laser |
| 2 |
Technique in endovenous non-thermal ablation (Glue) |
| 3 |
Ambulatory phlebectomy |
| 4 |
Venous stent for ICVO How I do it? |
| 5 |
Venous valve surgery in deep venous reflux How I do it? |
| 6 |
Ultrasound in CVD How I do it? |
| No |
Venous disease-TVF1 |
| 1 |
Opening remark by President of Asian Venous Forum & Chairman of Thai Venous Forum |
| 2 |
History of Asian Venous Forum |
| 3 |
Venous & lymphatic surgery 30 years' experience (1994 ~ 2024) |
| 4 |
How to avoid complications of foam sclerotherapy |
| 5 |
Cryo Laser & Cryo sclerotherapy How I do It |
| 6 |
BLAST - blue light activated sclerotherapy for cosmetic C1 disease |
| 7 |
How to manage venous malformations New techniques to manage huge lesion |
| 8 |
All about AASV |
| 9 |
CVD burden & challenges in Nepal |
| 10 |
Virtual Reality A new frontier in EVLT surgery & education for varicose vein |
| 11 |
Pathophysiology of recurrent varicose vein |
| 12 |
Are the vein diameter and the treatment distance related to postoperative obstruction? |
| 13 |
Management of tributary veins Simultaneous phlebectomy, Staged or ASVAL? |
| 14 |
New superficial venous devices undergoing trials Could they be game changers? |
| No |
Venous disease-TVF2 |
| 1 |
Choices of anticoagulants during thrombolysis for acute DVT |
| 2 |
CAT- Cancer-associated thrombosis A clinical scoping review and/or |
| 3 |
Asian VTE prophylaxis in surgical patients |
| 4 |
General considerations for treatment of acute iliofemoral DVT |
| 5 |
How to decrease the rate and severity of PTS after DVT |
| 6 |
How to treat refractory or recurrent diseases in patients who underwent prior ovarian vein embolization |
| 7 |
How to deal with combined Nutcracker syndrome and ovarian vein reflux |
| 8 |
Evidence-based aquatic protocol for vein-lymphatic patients |
| 9 |
Outcomes of deep venous reflux correction in chronic venous insufficiency |
| 10 |
Indications for intervention in NIVL |
| 11 |
Direct sampling mass spectrometry for the evaluation of venous leg ulcers |
| 12 |
CVD and obesity |
| 13 |
Skin care in CVD |
| |
Vascular Access |
| No |
Vascular access-Update guidelines & Innovations |
| 1 |
How to change and improve dialysis access care? |
| 2 |
The selection process of renal replacement therapy; Is it complex algorithm and poorly understood? |
| 3 |
Innovations and challenges in secondary and tertiary AVF |
| 4 |
Integrated dialysis access systems |
| 5 |
AVF formation with adjuvant endovascular maturation |
| 6 |
EndoAVF: Where are we now? |
| 7 |
Safety in dialysis access |
| 8 |
Role of bare-metal stent in dialysis access salvage |
| 9 |
Update in innovations to treat central vein occlusion in HD vascular access |
| 10 |
A novel outside-in transcervical mediastinal access for TCC replacement in central vein occlusion |
| No |
Vascular access-1 |
| 1 |
Obstacle in promoting preemptive AVF: a challenge problem |
| 2 |
A transformative AV conduit turning into a long-term living vessel |
| 3 |
Access surveillance: Who, When and How? |
| 4 |
Inside-out technique for central venous catheter insertion in CKD patient |
| 5 |
Diagnosis & management of AVF problems |
| 6 |
Lower extremity vascular access: Choice and Techniques. |
| 7 |
Femoral vein transposition under fascia iliaca block: How I do it? |
| 8 |
Isotonic vs. Isometric exercise: Which one is the best to boost AVF maturation? |
| 9 |
Open surgical repair for cephalic arch stenosis |
| 10 |
Bleeding complications in vascular access for hemodialysis |
| No |
Vascular access-2 |
| 1 |
How to avoid nightmare in TCC insertion? |
| 2 |
Juxta-anastomotic stenting: Techniques and Results |
| 3 |
Pathogenesis of giant aneurysm of AVF |
| 4 |
AV access aneurysm: How and when to intervene? |
| 5 |
Access banding: Surgical approach |
| 6 |
ECG-guided TCC catheter insertion: Dose it work? |
| 7 |
Minimal invasive vascular access for hemodialysis |
| 8 |
EndoAVF: Is it worth in Singapore setting? |
| 9 |
Adjunctive techniques to increase maturation rate of endoAVF |
| 10 |
Role of IVUS in access intervention |
| No |
Vascular access-3 |
| 1 |
How to prevent and treatment algorithm for HAIDI? |
| 2 |
How to choose appropriate balloon size for venoplasty in access stenosis? |
| 3 |
Drug eluting balloon in the AV access circuit |
| 4 |
Results of Sirolimus-coated balloon in AV access stenosis |
| 5 |
Drug eluting stent in access stenosis |
| 6 |
Different puncture sites for endovascular treatment in vascular access |
| 7 |
Percutaneous AVG thrombectomy with manual pulse spray techniques |
| 8 |
Evaluation of the end point of thrombosed AVF salvage |
| 9 |
High pressure vs. cutting balloon in AV access stenosis |
| 10 |
Does stent graft prolong reintervention in outflow stenosis? |
| No |
Vascular access-Asia |
| 1 |
Innovations in vascular access: Cutting edge techniques and tools. |
| 2 |
Management of immature AVF |
| 3 |
Treatment strategies for recurrent vascular access stenosis |
| 4 |
Central venous occlusion: Role of the HERO graft |
| No |
Vascular access-How I do it? |
| 1 |
US-guided venoplasty in access dysfunction |
| 2 |
AV Graft / AVF salvage by mechanical thrombectomy. |
| |
Vascular Trauma |
| No |
Vascular trauma |
| 1 |
Role of endovascular procedure in vascular trauma |
| 2 |
Current management of vascular trauma in neck region |
| 3 |
Current management of vascular trauma in thoracic region |
| 4 |
Current management of vascular trauma in abdominal region |
| 5 |
Current management of vascular trauma in extremity region |
| 6 |
REBOA in severe intraabdominal traumatic hemorrhage |
| 7 |
Iatrogenic vascular injury |
| 8 |
How to manage major vascular trauma in military & austere settings |
| 9 |
My experience of 10 missions with MSF (more than 12 months working “in-the-field”) |
| 10 |
A common presentation in war zones, the mangled extremity is a complex, multispecialty problem |
| No |
Vascular trauma-Asia |
| 1 |
Thoracic aortic injury in Vietnam |
| 2 |
Peripheral vascular Injury in Vietnam |